CompletedNCT01323192
JNS001 Compared With Placebo for Adult ADHD
About this title
Read the official source — NCT01323192Researchers compared JNS001 and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.
Medication studyAges 18–64Japan
Understand this study
What did researchers investigate?
Researchers compared JNS001 and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.
Who was this study for?
This study was for people with ADHD. Listed age limits: 18 years to 64 years. Other eligibility criteria applied.
- Listed locations
- Chiba and 29 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateMarch 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 284
- Sponsor
- Janssen Pharmaceutical K.K.
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Japan
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT01323192
- Official title
Show the full official title
A Double-blind, Placebo-controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of JNS001 in Adults With Attention-Deficit/Hyperactivity Disorder at Doses of 18 mg, 36 mg, 54 mg, or 72 mg Per Day
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedChiba · Chigasaki · Chiyoda City
27 more locations
- Fuchū
- Fukuoka
- Fukushima
- Hamamatsu
- Higashiosaka
- Ichikawa
- Iruma
- Isehara
- Kashihara
- Kishiwada
- Kobe
- Kumamoto
- Kurume
- Matsuyama
- Nagasaki
- Nagoya
- Nara
- Neyagawa
- Osaka
- Saitama
- Sakai
- Sapporo
- Setagaya City
- Shibuya City
- Takatsuki
- Tokyo
- Yokohama
Questions about this study
What did researchers investigate?
Researchers compared JNS001 and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.
Who is behind this study?
The study sponsor is Janssen Pharmaceutical K.K., a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including JNS001 and Placebo.
Who was this study for?
This study was for people with ADHD. Listed age limits: 18 years to 64 years. Other eligibility criteria applied.
